Home BPCIA: Amgen Begins the Patent Dance With AbbVie
 

Keywords :   


BPCIA: Amgen Begins the Patent Dance With AbbVie

2015-12-08 00:56:18| Biotech - Topix.net

On November 25, 2015, Amgen Inc. announced it submitted its first biologics license application to the FDA under the Section 351 biosimilar approval pathway provided in the Biologics Price Competition and Innovation Act . Amgen's BLA seeks approval for its biosimilar of AbbVie's top-selling arthritis drug Humira .

Tags: dance begins patent amgen

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.07Atlantic Tropical Weather Outlook
05.07Eastern North Pacific Tropical Weather Outlook
04.07Hurricane Beryl Graphics
04.07Hurricane Beryl Forecast Discussion Number 25
04.07Hurricane Beryl Public Advisory Number 25
04.07Summary for Hurricane Beryl (AT2/AL022024)
04.07Hurricane Beryl Wind Speed Probabilities Number 25
04.07Hurricane Beryl Forecast Advisory Number 25
More »